ALGN:NGS-Align Technology Inc.

EQUITY | Medical Devices | Nasdaq Global Select

Last Closing

USD 290.06

Change

+1.38 (+0.48)%

Market Cap

USD 7.53B

Volume

1.10M

Analyst Target

USD 339.13
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-06-18 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

-2.66 (-1.95%)

USD 51.34B
BRKR Bruker Corporation

-0.95 (-1.13%)

USD 12.93B
PODD Insulet Corporation

-6.45 (-3.73%)

USD 11.49B
SWAV Shockwave Medical Inc

N/A

USD 10.25B
MASI Masimo Corporation

-1.56 (-1.13%)

USD 7.14B
AXNX Axonics Modulation Technologie..

-0.14 (-0.21%)

USD 3.43B
IRTC iRhythm Technologies Inc

+1.64 (+1.49%)

USD 3.36B
QDEL Quidel Corporation

-1.59 (-3.95%)

USD 3.14B
LIVN LivaNova PLC

-1.31 (-2.46%)

USD 3.02B
IART Integra LifeSciences Holdings

+0.12 (+0.38%)

USD 2.64B

ETFs Containing ALGN

EKG First Trust Nasdaq Lux Di.. 5.26 % 0.00 %

-0.18 (-0.27%)

USD 1.51M
UGCE 3.86 % 0.00 %

N/A

N/A
XS2D:LSE Xtrackers S&P 500 2x Leve.. 3.55 % 0.00 %

-1.47 (-0.27%)

USD 0.29B
DBPG:F Xtrackers - S&P 500 2x Le.. 3.55 % 0.00 %

-2.72 (-0.27%)

USD 0.32B
DBPG:XETRA Xtrackers S&P 500 2x Leve.. 3.55 % 0.00 %

-2.20 (-0.27%)

USD 0.32B
QQJG Invesco ESG NASDAQ Next G.. 1.83 % 0.00 %

-0.15 (-0.27%)

USD 5.60M
QQJE:CA Invesco ESG NASDAQ Next G.. 1.79 % 0.00 %

N/A

CAD 0.93M
RSPH Invesco S&P 500® Equal.. 1.63 % 0.00 %

-0.22 (-0.27%)

USD 1.02B
EQQJ:LSE Invesco NASDAQ Next Gener.. 1.59 % 0.00 %

-0.15 (-0.27%)

USD 0.05B
EQQJ:XETRA Invesco NASDAQ Next Gener.. 1.57 % 0.00 %

-0.20 (-0.27%)

USD 0.03B
EQQJ:SW Invesco NASDAQ Next Gener.. 1.57 % 0.00 %

-0.46 (-0.27%)

N/A
EQJS:LSE Invesco NASDAQ Next Gener.. 1.55 % 0.00 %

-15.25 (-0.27%)

USD 0.03B
HIBL Direxion Daily S&P 500® .. 0.92 % 0.00 %

-0.71 (-0.27%)

USD 0.07B
SP2D:XETRA Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

-0.28 (-0.27%)

USD 0.19B
SP2Q:XETRA Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

-0.31 (-0.27%)

USD 0.20B
EWSP:LSE iShares S&P 500 Equal Wei.. 0.25 % 0.00 %

-0.02 (-0.27%)

USD 1.19B
XDEE:XETRA Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

-0.04 (-0.27%)

USD 6.39B
XDED:XETRA Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

-0.42 (-0.27%)

USD 6.30B
XDEW:SW Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

-0.21 (-0.27%)

USD 5.87B
EWSP:SW iShares S&P 500 Equal Wei.. 0.23 % 0.00 %

N/A

USD 1.19B
RSP Invesco S&P 500® Equal W.. 0.00 % 0.20 %

-0.33 (-0.27%)

USD 52.39B
RYH Invesco S&P 500® Equal W.. 0.00 % 0.40 %

N/A

USD 1.01B
SPHB Invesco S&P 500® High Be.. 0.00 % 0.25 %

-0.51 (-0.27%)

USD 0.49B
XHE SPDR® S&P Health Care Eq.. 0.00 % 0.35 %

-0.78 (-0.27%)

USD 0.30B
BMED BlackRock Future Health E.. 0.00 % 0.00 %

-0.14 (-0.27%)

USD 4.14M
QQQJ Invesco NASDAQ Next Gen 1.. 0.00 % 0.00 %

-0.19 (-0.27%)

USD 0.72B
QQQN VictoryShares Nasdaq Next.. 0.00 % 0.00 %

-0.20 (-0.27%)

USD 0.02B
DTEC ALPS Disruptive Technolog.. 0.00 % 0.00 %

-0.23 (-0.27%)

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 38.50% 78% C+ 85% B
Dividend Return N/A N/A N/A N/A F
Total Return 38.50% 78% C+ 84% B
Trailing 12 Months  
Capital Gain -21.63% 56% F 37% F
Dividend Return N/A N/A N/A N/A F
Total Return -21.63% 56% F 36% F
Trailing 5 Years  
Capital Gain 459.64% 91% A- 97% N/A
Dividend Return N/A N/A N/A N/A F
Total Return 459.64% 91% A- 97% N/A
Average Annual (5 Year Horizon)  
Capital Gain 59.26% 89% A- 95% A
Dividend Return 59.26% 89% A- 95% A
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 53.01% 37% F 17% F
Risk Adjusted Return 111.79% 93% A 93% A
Market Capitalization 7.53B 100% F 97% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 40.90 15% 8%
Price/Book Ratio 19.40 10% 5%
Price / Cash Flow Ratio 11.03 11% 7%
Price/Free Cash Flow Ratio 70.06 5% 5%
Management Effectiveness  
Return on Equity 33.41% 84% 91%
Return on Invested Capital 38.94% 87% 94%
Return on Assets 20.85% 97% 97%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.